Orion Biotech Opportunities Common Stock

Orion Biotech Opportunities (ORIA) currently reports a common stock of $200M as of December 2022. That compares with $400M in the prior-year period — down 49.5% year over year. Use the charts on this page to explore Orion Biotech Opportunities's common stock history and peer comparisons.

Orion Biotech Opportunities's common stock decreased from $400M to $200M — a 49.5% year-over-year decrease (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Orion Biotech Opportunities reported $200M in common stock as of December 2022. That compares with $400M in the prior-year period — down 49.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $200M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Orion Biotech Opportunities, and consider following ORIA for alerts when major investors trade the stock.